Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 990 | 919 | 943 | 908 | 1149 | - |
Fund Return | -1.01% | -8.11% | -5.75% | -3.15% | 2.82% | - |
Place in category | 2333 | 2374 | 2706 | 1818 | 1355 | - |
% in Category | 80 | 77 | 95 | 90 | 94 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Mirabaud Eq Glbl Focus I GBP Acc | 230.87M | -1.08 | -3.23 | - | ||
Mirabaud Glbl Eq HiIncome D GBP Inc | 68.55M | 1.31 | 5.89 | - | ||
Mirabaud Glbl Eq HiIncome D GBP Acc | 68.55M | 1.31 | 5.89 | - | ||
Mirabaud Glbl Eq HiIncome A GBP Inc | 68.55M | 0.56 | 4.96 | - | ||
Mirabaud Glbl Eq HiIncome I GBP Inc | 68.55M | 1.24 | 5.81 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2322252383 | 13.63B | 8.01 | 4.60 | - | ||
Cap Group New Perspective lux C GBP | 13.63B | 8.20 | 5.30 | - | ||
Cap Group NewPerspective lux ZL GBP | 13.63B | 8.03 | 4.70 | 10.35 | ||
Cap Group NewPerspective lux A7 GBP | 13.63B | 8.04 | 4.82 | - | ||
CapGroup NewPerspective lux ZLd GBP | 13.63B | 8.06 | 4.70 | 10.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.89 | 406.66 | +2.22% | |
Mastercard | US57636Q1040 | 4.96 | 443.61 | +0.57% | |
Novo Nordisk A/S Class B | DK0060534915 | 4.65 | - | - | |
Wolters Kluwer | NL0000395903 | 4.47 | 143.60 | +2.02% | |
L'Oreal | FR0000120321 | 4.45 | 440.90 | +0.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Strong Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Strong Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review